Helping BRCA+ mothers communicate about breast cancer risks
Parent Communication Study IV: Improving Genetic Counseling for BRCA+ Mothers
This study is trying to help mothers with the BRCA gene mutation learn how to talk to their kids about breast cancer risks and provide them with the right support and information.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Georgetown University Academic / other |
| Locations | 1 site (Washington D.C., District of Columbia) |
| Trial ID | NCT04258280 on ClinicalTrials.gov |
What this trial studies
This study focuses on improving genetic counseling for mothers who carry the BRCA gene mutation, which increases the risk of breast cancer. It aims to educate these mothers on how to discuss genetic risks with their children aged 13-24, providing them with appropriate information and emotional support. The intervention includes educational resources and counseling to enhance their psychological well-being and decision-making regarding sharing genetic information. The study seeks to empower mothers to make informed choices about discussing hereditary breast cancer with their families.
Who should consider this trial
Good fit: Ideal candidates for this study are mothers or primary caregivers of adolescents and young adults aged 13-24 who are undergoing genetic testing for hereditary breast cancer.
Not a fit: Patients who do not have children or primary caregivers in the specified age range may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help mothers better communicate genetic risks to their children, potentially leading to earlier detection and prevention of breast cancer.
How similar studies have performed: While there is ongoing research in genetic counseling, this specific approach to educating BRCA+ mothers about communication with their children is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Mothers/primary caregivers to adolescents/young adults ages 13-24 years-old. * Participating in genetic testing for hereditary breast cancer. * Adequately speak/read English. Exclusion Criteria: \- Does not meet inclusion criteria.
Where this trial is running
Washington D.C., District of Columbia
- MedStar Georgetown University Hospital — Washington D.C., District of Columbia, United States (Recruiting)
Study contacts
- Study coordinator: Kenneth Tercyak, PhD
- Email: familycom@georgetown.edu
- Phone: 202-687-0802
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.